Director, Clinical Science (Hematology)
BeiGene
Summary
As the Director, Clinical Science you will support BeOne Clinical and Medical assets by successful execution of clinical development programs and deliverables in partnership across the organization, external vendors, external academicians and collaboration partners.
Job description
As a leader in the organization, you will be accountable to jointly develop clinical program strategy and help assure that activities are executed within expected scope, budget and timelines. You will play a key role in the establishment and growth of Clinical Research functions to assure best-in-class global capabilities and execution.
You will work closely with colleagues in clinical development, program leadership, biometrics, clinical operations, safety/pharmacovigilance, regulatory, molecular diagnostics, and translational research.
Requirements
- Master's Degree and 7+ years of experience within a clinical and/or scientific profession and 5+ years of professional or clinical experience within other biotech/pharmaceutical companies required. MD, PharmD or PhD highly preferred.
- Previous participation in a clinical development program is essential, including involvement in all stages of clinical trials (i.e. from start up to study report), ideally having taken at least one study through from start to finish in a clinical scientist role.
- Clinical Hematology experience; candidates with exceptional experience in other therapeutic areas would be considered if they demonstrated clear potential to apply their existing skills to hematology.
- Expert understanding of global clinical study design and drug development process from discovery to registration and post-marketing.
- High level of communication (written and verbal), interpersonal, organizational, and cross functional collaboration skills.
- Knowledge of GCP and ICH Guidelines.
- Flexibility to work with colleagues in a global setting.
- Experience with the development and support of related SOPs and policies is expected.
- Knowledge of industry standard Clinical Development IT solutions expected.
- Travel: approximately 25%.
Preferred
- Strategic leader with demonstrated success building, managing and developing individuals and teams.
Requirements
- Master's Degree and 7+ years of experience within a clinical and/or scientific profession
- 5+ years of professional or clinical experience within biotech/pharmaceutical companies
- MD, PharmD or PhD highly preferred
- Previous participation in a clinical development program, including all stages of clinical trials
- Clinical Hematology experience
- Expert understanding of global clinical study design and drug development process
- High level of communication, interpersonal, organizational, and cross functional collaboration skills
- Knowledge of GCP and ICH Guidelines
- Flexibility to work with colleagues in a global setting
- Experience with development and support of related SOPs and policies
- Knowledge of industry standard Clinical Development IT solutions
- Travel approximately 25%
- Strategic leader with demonstrated success building, managing and developing individuals and teams
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Annual Bonus Plan
- Equity Awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.